Your browser doesn't support javascript.
loading
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma.
Tuazon, Sherilyn A; Cassaday, Ryan D; Gooley, Theodore A; Sandmaier, Brenda M; Holmberg, Leona A; Smith, Stephen D; Maloney, David G; Till, Brian G; Martin, Daniel B; Chow, Victor A; Rajendran, Joseph G; Fisher, Darrell R; Matesan, Manuela C; Lundberg, Sally J; Green, Damian J; Pagel, John M; Press, Oliver W; Gopal, Ajay K.
Afiliação
  • Tuazon SA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington.
  • Gooley TA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Smith SD; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Till BG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Martin DB; Department of Medicine, Division of Hematology, University of Washington, Seattle, Washington.
  • Chow VA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Rajendran JG; Department of Nuclear Medicine, University of Washington, Seattle, Washington.
  • Fisher DR; Versant Medical Physics and Radiation Safety, Richland, Washington.
  • Matesan MC; Department of Nuclear Medicine, University of Washington, Seattle, Washington.
  • Lundberg SJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Green DJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Pagel JM; Swedish Cancer Institute, Seattle, Washington.
  • Press OW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington.
  • Gopal AK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington. Electronic address: agopal@uw.edu.
Transplant Cell Ther ; 27(1): 57.e1-57.e8, 2021 01.
Article em En | MEDLINE | ID: mdl-32980545
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma Limite: Adult / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article